AIRS Medical Raises $20 Million in Series C

by Kay Aloha Villamor in July 11th, 2024

AIRS Medical, a Seoul, South Korea-based company that provides AI-powered healthcare solutions, has raised $20 million in Series C funding. 


The investment came from Korean institutional investors, including BSK Investment and Shinyoung Securities. 

BSK Investment is a venture capital firm based in Seoul, South Korea. The firm focuses on investing in startups to pre-IPO stage companies in sectors such as information technology, bio/healthcare, chemicals, materials, and energy. 

Shinyoung Securities, founded in 1956 and headquartered in Seoul, South Korea, is an investment banking firm specializing in brokering and trading services for stocks, bonds, futures, and options. They also offer research on domestic and international financial markets, wealth management, and various investment banking services. 

AIRS Medical Use of Funds 

The company will use the funding to support its expansion into international markets, further R&D efforts, and enhance global access to its innovative healthcare solutions. 

About AIRS Medical 

Founded in 2018, AIRS Medical is a healthcare AI company specializing in artificial intelligence and robotics for healthcare applications. They offer solutions for MRI enhancement and automated venipuncture, utilizing AI to improve medical imaging and clinical procedures. Their flagship product, SwiftMR, employs deep learning technology to significantly enhance the speed and efficiency of MRI scans, reducing scan times by up to 50%. This increases patient throughput and lowers operational costs for radiology centers and hospitals. The company has expanded internationally, with a presence in markets such as the United States and Europe. 

Funding Details  

Company: AIRS Medical Inc. 

Raised: $20.0M  

Round: Series C 

Funding Month: July 2024  

Investors: BSK Investment, Shinyoung Securities 

Company Website:  

Software Category: AI Healthcare Solutions 


Your cart